OA13017A - Diazepinoindole derivatives as kinase inhibitors. - Google Patents
Diazepinoindole derivatives as kinase inhibitors. Download PDFInfo
- Publication number
- OA13017A OA13017A OA1200500197A OA1200500197A OA13017A OA 13017 A OA13017 A OA 13017A OA 1200500197 A OA1200500197 A OA 1200500197A OA 1200500197 A OA1200500197 A OA 1200500197A OA 13017 A OA13017 A OA 13017A
- Authority
- OA
- OAPI
- Prior art keywords
- phenyl
- oxo
- dihydro
- diazepino
- indol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43939603P | 2003-01-09 | 2003-01-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA13017A true OA13017A (en) | 2006-11-10 |
Family
ID=32713475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA1200500197A OA13017A (en) | 2003-01-09 | 2004-01-05 | Diazepinoindole derivatives as kinase inhibitors. |
Country Status (35)
Country | Link |
---|---|
US (3) | US6967198B2 (fr) |
EP (2) | EP1585749B1 (fr) |
JP (1) | JP3990718B2 (fr) |
KR (1) | KR100697746B1 (fr) |
CN (1) | CN1759118B (fr) |
AP (1) | AP2048A (fr) |
AT (1) | ATE404564T1 (fr) |
AU (1) | AU2004203977B2 (fr) |
BR (1) | BRPI0406701A (fr) |
CA (1) | CA2512683C (fr) |
CR (1) | CR7899A (fr) |
CY (1) | CY1108408T1 (fr) |
DE (1) | DE602004015724D1 (fr) |
DK (1) | DK1585749T3 (fr) |
EA (1) | EA009337B1 (fr) |
EC (1) | ECSP055911A (fr) |
ES (1) | ES2309484T3 (fr) |
GE (1) | GEP20084367B (fr) |
HK (1) | HK1086257A1 (fr) |
HR (1) | HRP20050624A2 (fr) |
IL (1) | IL169082A (fr) |
IS (1) | IS7884A (fr) |
MA (1) | MA27703A1 (fr) |
MX (1) | MXPA05007352A (fr) |
NO (1) | NO20053775L (fr) |
NZ (1) | NZ540638A (fr) |
OA (1) | OA13017A (fr) |
PL (1) | PL378372A1 (fr) |
PT (1) | PT1585749E (fr) |
RS (1) | RS20050522A (fr) |
SI (1) | SI1585749T1 (fr) |
TN (1) | TNSN05176A1 (fr) |
UA (1) | UA80733C2 (fr) |
WO (1) | WO2004063198A1 (fr) |
ZA (1) | ZA200504674B (fr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2473886C (fr) * | 2002-01-22 | 2012-08-21 | The Regents Of The University Of California | Ligands non steroidiens pour le recepteur des corticoides, compositions et utilisations desdits ligands |
WO2004063198A1 (fr) * | 2003-01-09 | 2004-07-29 | Pfizer Inc. | Derives de diazepinoindole en tant qu'inhibiteurs de kinase |
AU2006215413B2 (en) * | 2005-02-18 | 2010-10-07 | Astrazeneca Ab | Method for determining responsiveness to CHK1 inhibitors |
RS51616B (en) | 2005-03-29 | 2011-08-31 | Icos Corporation | HETEROARYL UREE DERIVATIVES USEFUL TO INHIBIT CHK1 |
GB0510390D0 (en) * | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
PL1896040T3 (pl) | 2005-06-29 | 2012-12-31 | Threshold Pharmaceuticals Inc | Proleki alkilatora fosforoamidowego |
EP1928907A4 (fr) | 2005-08-15 | 2009-03-11 | Univ California | Ligands fas actives par vegf |
JP4935675B2 (ja) | 2005-08-25 | 2012-05-23 | 宇部興産株式会社 | 光学活性(S又はR)−α−アミノ酸及び光学活性(R又はS)−α−アミノ酸エステルの製造方法 |
EP1916896A4 (fr) * | 2005-08-26 | 2010-08-11 | Univ California | Antiandrogenes non steroidiens |
US20090312280A1 (en) * | 2006-04-04 | 2009-12-17 | Pfizer Inc. | Combination therapy of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4-yl)-1-oxo-2,6-dihydro-1h-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide |
EP2004655A1 (fr) * | 2006-04-04 | 2008-12-24 | Pfizer Products Incorporated | Formes polymorphes de (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-méthyl-1h-pyrazol-4 l)-1-oxo-2,6-dihydro-1h-ý1,2¨diazépinoý4,5,6-cd¨indol-8-yl)acétamide |
EP2086644A2 (fr) * | 2006-11-17 | 2009-08-12 | Schering Corporation | Combinaison d'un inhibiteur de l'adn polymerase-alpha avec un inhibiteur d'une kinase de point de controle pour le traitement des maladies proliferatives |
US8158656B2 (en) * | 2008-05-16 | 2012-04-17 | Shenzhen Chipscreen Biosciences Ltd. | 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors |
WO2010016005A1 (fr) * | 2008-08-06 | 2010-02-11 | Pfizer Inc. | Composés 2-hétérocyclylamino pyrazines substituées en position 6 en tant qu'inhibiteurs de chk-1 |
EP2346881A1 (fr) * | 2008-10-10 | 2011-07-27 | Priaxon AG | Nouveaux composés qui modulent l'activité kinase |
US8314108B2 (en) | 2008-12-17 | 2012-11-20 | Eli Lilly And Company | 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile, pharmaceutically acceptable salts thereof, or solvate of salts |
US8663210B2 (en) | 2009-05-13 | 2014-03-04 | Novian Health, Inc. | Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy |
US8211901B2 (en) | 2009-05-22 | 2012-07-03 | Shenzhen Chipscreen Biosciences Ltd. | Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors |
CN101906076B (zh) | 2009-06-04 | 2013-03-13 | 深圳微芯生物科技有限责任公司 | 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用 |
JP5941981B2 (ja) | 2011-05-06 | 2016-06-29 | ザフゲン,インコーポレイテッド | 三環式スルホンアミド化合物ならびにその製造および使用方法 |
WO2013096687A1 (fr) * | 2011-12-22 | 2013-06-27 | Threshold Pharmaceuticals, Inc. | Administration de promédicaments activés par l'hypoxie en combinaison à des inhibiteurs de chk1 pour le traitement du cancer |
ME02855B (fr) | 2011-12-31 | 2018-04-20 | Beigene Ltd | Dihydrodiazépinocarbazolones tétra ou pentacycliques fusionnés à utiliser en tant qu'inhibiteurs de parp |
AU2011384859B2 (en) | 2011-12-31 | 2016-03-17 | Beigene, Ltd. | Fused tetra or penta-cyclic pyridophthalazinones as PARP inhibitors |
CN102746211B (zh) * | 2012-06-27 | 2015-05-27 | 上海泰坦化学有限公司 | 一种取代吲哚-3-甲醛类化合物的制备方法 |
TWI633107B (zh) * | 2013-05-22 | 2018-08-21 | 開曼群島商百濟神州生物科技有限公司 | 作為parp抑制劑的稠合四或五環二氫二氮呯并咔唑酮 |
US9974774B2 (en) | 2013-07-26 | 2018-05-22 | Race Oncology Ltd. | Combinatorial methods to improve the therapeutic benefit of bisantrene and analogs and derivatives thereof |
US10071109B2 (en) | 2013-11-06 | 2018-09-11 | Molecular Templates, Inc. | Predictive biomarker for hypoxia-activated prodrug therapy |
SG10201811175WA (en) | 2014-06-17 | 2019-01-30 | Vertex Pharma | Method for treating cancer using a combination of chk1 and atr inhibitors |
NZ739876A (en) | 2015-08-25 | 2022-09-30 | Beigene Ltd | Process for preparing parp inhibitor, crystalline forms, and uses thereof |
EP3355926A4 (fr) | 2015-09-30 | 2019-08-21 | Vertex Pharmaceuticals Inc. | Méthode de traitement du cancer utilisant une association d'agents endommageant l'adn et d'inhibiteurs de l'atr |
EP3519051B1 (fr) | 2016-09-27 | 2021-09-22 | Beigene, Ltd. | Traitement de cancers à l'aide d'une combinaison comprenant des inhibiteurs de parp |
JP6541635B2 (ja) * | 2016-10-28 | 2019-07-10 | ベイジーン リミテッド | Parp阻害剤としての縮合四環式または縮合五環式ジヒドロジアゼピノカルバゾロン |
CN115433187B (zh) | 2017-02-28 | 2023-10-27 | 百济神州(苏州)生物科技有限公司 | 稠合的四环或五环二氢二氮杂䓬并咔唑酮的盐的结晶形式组合物及其用途 |
US11661581B2 (en) * | 2017-05-25 | 2023-05-30 | University Of Massachusetts | Use of CDK inhibitors to enhance growth and self-renewal of progenitor cells |
MX2020003242A (es) * | 2017-09-22 | 2020-09-18 | Jubilant Epipad LLC | Compuestos heterociclicos como inhibidores de pad. |
EP3461480A1 (fr) | 2017-09-27 | 2019-04-03 | Onxeo | Combinaison d'inhibiteurs de point de contrôle du cycle cellulaire de réponse à un dommage à l'adn et de belinostat pour traiter le cancer |
JP2022523028A (ja) * | 2019-01-25 | 2022-04-21 | ヌメディー, インコーポレイテッド | 特発性肺線維症を処置するための方法 |
WO2021018298A1 (fr) * | 2019-08-01 | 2021-02-04 | 南京明德新药研发有限公司 | Composés acyloxime à sept chaînons indolo servant d'inhibiteurs de parp |
CN114746413B (zh) | 2019-11-29 | 2024-02-23 | 南京明德新药研发有限公司 | 二氮杂吲哚类衍生物及其作为Chk1抑制剂的应用 |
CA3184988A1 (fr) * | 2020-07-13 | 2022-01-20 | Ahmed Mamai | Conjugues inhibiteurs de nicotinamide phosphoribosyltransferase (nampt) et leurs utilisations |
WO2022022664A1 (fr) * | 2020-07-31 | 2022-02-03 | 正大天晴药业集团股份有限公司 | Cristal analogue d'indolo heptamyl-oxime en tant qu'inhibiteur de parp et procédé de préparation associé |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9722320D0 (en) | 1997-10-22 | 1997-12-17 | Janssen Pharmaceutica Nv | Human cell cycle checkpoint proteins |
US6383744B1 (en) | 1998-07-10 | 2002-05-07 | Incyte Genomics, Inc. | Human checkpoint kinase |
WO2000016781A1 (fr) | 1998-09-18 | 2000-03-30 | Smithkline Beecham Corporation | Inhibiteurs de la kinase chk1 |
KR100632079B1 (ko) | 1999-01-11 | 2006-10-04 | 아구론 파마슈티컬스, 인크. | 폴리(adp-리보오스) 중합 효소의 트리사이클릭 저해제 |
AU7070800A (en) | 1999-08-27 | 2001-03-26 | Chiron Corporation | Chimeric antisense oligonucleotides and cell transfecting formulations thereof |
ECSP003637A (es) | 1999-08-31 | 2002-03-25 | Agouron Pharma | Inhibidores triciclicos de poli (adp-ribosa) polimerasas |
US6670167B1 (en) | 1999-11-01 | 2003-12-30 | Agouron Pharmaceuticals, Inc. | Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof |
DK1218494T3 (da) | 1999-09-22 | 2005-08-08 | Canbas Co Ltd | Præparater og fremgangsmåder til inhibering af C2-cellecyklusstandsning og sensibilisering af celler til DNA-beskadigende midler |
US6211164B1 (en) | 2000-03-10 | 2001-04-03 | Abbott Laboratories | Antisense oligonucleotides of the human chk1 gene and uses thereof |
WO2002044183A2 (fr) | 2000-12-01 | 2002-06-06 | Guilford Pharmaceuticals Inc. | Composes et leurs utilisations |
UA76977C2 (en) | 2001-03-02 | 2006-10-16 | Icos Corp | Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers |
WO2004063198A1 (fr) * | 2003-01-09 | 2004-07-29 | Pfizer Inc. | Derives de diazepinoindole en tant qu'inhibiteurs de kinase |
-
2004
- 2004-01-05 WO PCT/IB2004/000026 patent/WO2004063198A1/fr active IP Right Grant
- 2004-01-05 GE GEAP20048886A patent/GEP20084367B/en unknown
- 2004-01-05 SI SI200430830T patent/SI1585749T1/sl unknown
- 2004-01-05 AP AP2005003353A patent/AP2048A/xx active
- 2004-01-05 PT PT04700145T patent/PT1585749E/pt unknown
- 2004-01-05 ES ES04700145T patent/ES2309484T3/es not_active Expired - Lifetime
- 2004-01-05 BR BR0406701-0A patent/BRPI0406701A/pt not_active IP Right Cessation
- 2004-01-05 CN CN2004800063838A patent/CN1759118B/zh not_active Expired - Fee Related
- 2004-01-05 EP EP04700145A patent/EP1585749B1/fr not_active Expired - Lifetime
- 2004-01-05 NZ NZ540638A patent/NZ540638A/en unknown
- 2004-01-05 JP JP2006500278A patent/JP3990718B2/ja not_active Expired - Fee Related
- 2004-01-05 EA EA200500893A patent/EA009337B1/ru not_active IP Right Cessation
- 2004-01-05 OA OA1200500197A patent/OA13017A/en unknown
- 2004-01-05 DK DK04700145T patent/DK1585749T3/da active
- 2004-01-05 AU AU2004203977A patent/AU2004203977B2/en not_active Ceased
- 2004-01-05 CA CA2512683A patent/CA2512683C/fr not_active Expired - Fee Related
- 2004-01-05 KR KR1020057012806A patent/KR100697746B1/ko not_active IP Right Cessation
- 2004-01-05 AT AT04700145T patent/ATE404564T1/de not_active IP Right Cessation
- 2004-01-05 PL PL378372A patent/PL378372A1/pl not_active Application Discontinuation
- 2004-01-05 RS YUP-2005/0522A patent/RS20050522A/sr unknown
- 2004-01-05 MX MXPA05007352A patent/MXPA05007352A/es active IP Right Grant
- 2004-01-05 EP EP08155745A patent/EP1947102A1/fr not_active Withdrawn
- 2004-01-05 DE DE602004015724T patent/DE602004015724D1/de not_active Expired - Lifetime
- 2004-01-09 US US10/754,171 patent/US6967198B2/en not_active Expired - Fee Related
- 2004-05-01 UA UAA200506730A patent/UA80733C2/uk unknown
-
2005
- 2005-06-08 ZA ZA200504674A patent/ZA200504674B/en unknown
- 2005-06-08 IL IL169082A patent/IL169082A/en not_active IP Right Cessation
- 2005-06-09 IS IS7884A patent/IS7884A/is unknown
- 2005-07-07 HR HR20050624A patent/HRP20050624A2/hr not_active Application Discontinuation
- 2005-07-08 CR CR7899A patent/CR7899A/es unknown
- 2005-07-08 MA MA28375A patent/MA27703A1/fr unknown
- 2005-07-08 EC EC2005005911A patent/ECSP055911A/es unknown
- 2005-07-08 TN TNP2005000176A patent/TNSN05176A1/fr unknown
- 2005-07-22 US US11/187,089 patent/US7132533B2/en not_active Expired - Fee Related
- 2005-08-08 NO NO20053775A patent/NO20053775L/no unknown
-
2006
- 2006-05-26 HK HK06106153.4A patent/HK1086257A1/xx not_active IP Right Cessation
- 2006-06-23 US US11/426,132 patent/US7462713B2/en not_active Expired - Fee Related
-
2008
- 2008-10-13 CY CY20081101127T patent/CY1108408T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA13017A (en) | Diazepinoindole derivatives as kinase inhibitors. | |
RU2730552C2 (ru) | Спироконденсированные пирролидиновые производные в качестве ингибиторов деубиквитилирующих ферментов (DUB) | |
CN113286794B (zh) | Kras突变蛋白抑制剂 | |
JP2022541483A (ja) | Parp1阻害薬 | |
EP2321316B1 (fr) | Dérivés de pyrimidin-4-one substitués | |
WO2017158388A1 (fr) | Dérivés de 2-cyanoisoindoline pour le traitement du cancer | |
EA039783B1 (ru) | ПРОИЗВОДНЫЕ ТИРОЗИНАМИДА В КАЧЕСТВЕ ИНГИБИТОРОВ Rho-КИНАЗЫ | |
JP5581220B2 (ja) | 置換ヘテロアリールアミドオキサゼピノピリミドン誘導体 | |
US9221826B2 (en) | Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases | |
TW200936588A (en) | Substituted heteroarylamide diazepinopyrimidone derivatives | |
CN113454082A (zh) | 咪唑并吡啶基化合物及其用于治疗神经退行性疾病的用途 | |
CA3117319A1 (fr) | Heterocycles bicycliques fusionnes en tant qu'agents therapeutiques | |
CN112654354A (zh) | 1,3,4,9-四氢-2H-吡啶并[3,4-b]吲哚衍生物化合物及其用途 | |
ES2969088T3 (es) | Derivados de 1,4-dihidrobenzo[d]pirazolo[3,4-f][1,3]diazepina y compuestos relacionados como moduladores de quinasa LRRK2, NUAK1 y/o TYK2 para el tratamiento de e.g. enfermedades autoinmunes | |
CN115667218A (zh) | 激酶抑制剂 | |
TW202023548A (zh) | 新穎噻唑衍生物以及其藥用可接受鹽類 |